Myositis News and Research

RSS
Myositis is inflammation of your skeletal muscles, which are also called the voluntary muscles. These are the muscles you consciously control that help you move your body. An injury, infection or autoimmune disease can cause myositis. The diseases dermatomyositis and polymyositis both involve myositis. Polymyositis causes muscle weakness, usually in the muscles closest to the trunk of your body. Dermatomyositis causes muscle weakness, plus a skin rash. Both diseases are usually treated with prednisone, a steroid medicine, and sometimes other medicines.
Researchers identify the culprit responsible for harmful inflammation in certain muscular disorders

Researchers identify the culprit responsible for harmful inflammation in certain muscular disorders

In-depth assessment of muscle biopsies in patients with long COVID

In-depth assessment of muscle biopsies in patients with long COVID

Proteomics reveals a distinct IFN-driven plasma cytokine response to COVID-19 in infants and young children

Proteomics reveals a distinct IFN-driven plasma cytokine response to COVID-19 in infants and young children

Researchers devise new biomarker-based strategy to screen for myocarditis caused by cancer treatment

Researchers devise new biomarker-based strategy to screen for myocarditis caused by cancer treatment

SARS-CoV-2 activates NLRP3 inflammasome

SARS-CoV-2 activates NLRP3 inflammasome

The health status and exercise capacity of COVID-19 survivors one year after hospital discharge

The health status and exercise capacity of COVID-19 survivors one year after hospital discharge

Post-acute sequelae of SARS-CoV-2 infection in children appears to be lower than in adults

Post-acute sequelae of SARS-CoV-2 infection in children appears to be lower than in adults

Targeting necroptosis using a necroptosis inhibitor lessens myositis-induced muscle weakness

Targeting necroptosis using a necroptosis inhibitor lessens myositis-induced muscle weakness

EULAR develops new recommendations for cardiovascular risk management

EULAR develops new recommendations for cardiovascular risk management

Current understanding of the link between COVID-19 and cardiovascular disease

Current understanding of the link between COVID-19 and cardiovascular disease

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases

Researchers identify mechanism by which dermatomyositis may develop in humans

Researchers identify mechanism by which dermatomyositis may develop in humans

UCI receives $4.2 million grant to study sporadic inclusion body myositis affecting aging adults

UCI receives $4.2 million grant to study sporadic inclusion body myositis affecting aging adults

Anti-phospholipid antibodies in severely ill patients not distinctive to COVID-19, says study

Anti-phospholipid antibodies in severely ill patients not distinctive to COVID-19, says study

Radiological images reveal how COVID virus can trigger the body to attack itself

Radiological images reveal how COVID virus can trigger the body to attack itself

SARS-CoV-2 triggers development of new-onset IgG autoantibodies in hospitalized COVID-19 patients

SARS-CoV-2 triggers development of new-onset IgG autoantibodies in hospitalized COVID-19 patients

EULAR publishes recommendations for management of rheumatic immune-related adverse events

EULAR publishes recommendations for management of rheumatic immune-related adverse events

Autoimmunity appears to be increasing in the U.S.

Autoimmunity appears to be increasing in the U.S.

Immune checkpoint inhibitors induce rheumatic and musculoskeletal diseases

Immune checkpoint inhibitors induce rheumatic and musculoskeletal diseases

Study reveals potential pathway for endothelial cells to avoid apoptosis

Study reveals potential pathway for endothelial cells to avoid apoptosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.